跳至主要内容
临床试验/NL-OMON26542
NL-OMON26542招募中不适用

A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study

Erasmus MC0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Erasmus MC
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Operable patients who are planned to undergo or who recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgical resection for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago-gastric junction
  • - Age =18
  • - Written, voluntary, informed consent.

排除标准

  • - Non-FDG-avid tumour at baseline PET-CT scan
  • - Initial treatment with endoscopic resection
  • - Patients who underwent of who are planned to undergo definitive chemoradiotherapy
  • - Language difficulty, dementia or altered mental status prohibiting the understanding and giving of informed consent.

研究者

发起方
Erasmus MC

相似试验

Surgery As Needed for Oesophageal cancer -2 | 临床试验